Literature DB >> 16503466

Q fever.

Neil R Parker1, Jennifer H Barralet, Alan Morton Bell.   

Abstract

Q fever is a zoonosis with many manifestations. The most common clinical presentation is an influenza-like illness with varying degrees of pneumonia and hepatitis. Although acute disease is usually self-limiting, people do occasionally die from this condition. Endocarditis is the most frequent chronic presentation. Although Q fever is widespread, practitioner awareness and clinical manifestations vary from region to region. Geographically limited studies suggest that chronic fatigue syndrome and cardiovascular disease are long-term sequelae. An effective whole-cell vaccine is licensed in Australia. Live and acellular vaccines have also been studied, but are not currently licensed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16503466     DOI: 10.1016/S0140-6736(06)68266-4

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  130 in total

Review 1.  Principles of antidote pharmacology: an update on prophylaxis, post-exposure treatment recommendations and research initiatives for biological agents.

Authors:  S Ramasamy; C Q Liu; H Tran; A Gubala; P Gauci; J McAllister; T Vo
Journal:  Br J Pharmacol       Date:  2010-10       Impact factor: 8.739

2.  Coxiella burnetii acid phosphatase inhibits the release of reactive oxygen intermediates in polymorphonuclear leukocytes.

Authors:  J Hill; J E Samuel
Journal:  Infect Immun       Date:  2010-11-15       Impact factor: 3.441

3.  Chronic Q fever-related dual-pathogen endocarditis: case series of three patients.

Authors:  Linda M Kampschreur; Jan Jelrik Oosterheert; Cornelia A de Vries Feyens; Corine E Delsing; Mirjam H A Hermans; Ingrid L L van Sluisveld; Peter J Lestrade; Nicole H M Renders; Peter Elsman; Peter C Wever
Journal:  J Clin Microbiol       Date:  2011-02-02       Impact factor: 5.948

4.  Real-time PCR with serum samples is indispensable for early diagnosis of acute Q fever.

Authors:  Peter M Schneeberger; Mirjam H A Hermans; Erik J van Hannen; Jeroen J A Schellekens; Alexander C A P Leenders; Peter C Wever
Journal:  Clin Vaccine Immunol       Date:  2009-12-23

5.  Histological characteristics of the abdominal aortic wall in patients with vascular chronic Q fever.

Authors:  Julia C J P Hagenaars; Olivier H J Koning; Ronald F F van den Haak; Bart A N Verhoeven; Nicole H M Renders; Mirjam H A Hermans; Peter C Wever; Robert Jan van Suylen
Journal:  Int J Exp Pathol       Date:  2014-06-23       Impact factor: 1.925

6.  Q fever seroprevalence in metropolitan samples is similar to rural/remote samples in Queensland, Australia.

Authors:  S J Tozer; S B Lambert; T P Sloots; M D Nissen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-04-16       Impact factor: 3.267

7.  Molecular prevalence of Coxiella burnetii in milk in Iran: a systematic review and meta-analysis.

Authors:  Saber Esmaeili; Ashraf Mohabati Mobarez; Mohammad Khalili; Ehsan Mostafavi; Pardis Moradnejad
Journal:  Trop Anim Health Prod       Date:  2019-02-11       Impact factor: 1.559

8.  Acute Q fever pneumonia: high-resolution computed tomographic findings in six patients.

Authors:  Felipe Mussi von Ranke; Fernanda Miraldi Clemente Pessoa; Felipe Batista Afonso; Josiani Bastos Gomes; Danielle Provençano Borghi; Alessandro Severo Alves de Melo; Edson Marchiori
Journal:  Br J Radiol       Date:  2019-01-04       Impact factor: 3.039

9.  Serology in chronic Q fever is still surrounded by question marks.

Authors:  M C A Wegdam-Blans; H T Tjhie; J M Korbeeck; M N Nabuurs-Franssen; L M Kampschreur; T Sprong; J A W Teijink; M P Koopmans
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-01-16       Impact factor: 3.267

10.  A systematic review of chronic fatigue syndrome: don't assume it's depression.

Authors:  James P Griffith; Fahd A Zarrouf
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.